Chemotherapy, AdjuvantAntineoplastic Combined Chemotherapy ProtocolsCombined Modality TherapyRadiation InjuriesRadiation DosageAntineoplastic AgentsRadiation, IonizingBreast NeoplasmsRadiotherapy, AdjuvantDose-Response Relationship, RadiationRadiotherapyNeoplasm StagingTreatment OutcomeRadiotherapy DosageDisease-Free SurvivalCisplatinRadiation ToleranceDoxorubicinFluorouracilCyclophosphamideNeoplasm Recurrence, LocalRadiationSurvival AnalysisAdjuvants, ImmunologicPrognosisSurvival RateRadiation OncologyRadiotherapy, ConformalRadiation ProtectionRadiotherapy, Intensity-ModulatedMethotrexateRadiation MonitoringNeoplasmsNeoadjuvant TherapyDose FractionationLung NeoplasmsFollow-Up StudiesAdenocarcinomaLymphatic MetastasisAntimetabolites, AntineoplasticDrug Administration SchedulePaclitaxelRadiation PneumonitisRadiotherapy Planning, Computer-AssistedCell Line, TumorTime FactorsRetrospective StudiesBrachytherapyBrain NeoplasmsTegafurMastectomyColonic NeoplasmsAdjuvants, PharmaceuticEpirubicinEtoposideCarcinoma, Non-Small-Cell LungRadiation-Sensitizing AgentsCranial IrradiationVinblastineCarboplatinNeoplasms, Radiation-InducedRadiometryDrug Resistance, NeoplasmAnthracyclinesKaplan-Meier EstimateAntineoplastic Agents, PhytogenicClinical Trials as TopicAntibiotics, AntineoplasticRadiation Injuries, ExperimentalLevamisoleChemoradiotherapyDrug Screening Assays, AntitumorHead and Neck NeoplasmsTaxoidsRadiosurgeryFreund's AdjuvantSarcomaGamma RaysNeoplasm MetastasisAntineoplastic Agents, AlkylatingRectal NeoplasmsOrganoplatinum CompoundsCarcinoma, Squamous CellTamoxifenCosmic RadiationRadiotherapy, High-EnergyRandomized Controlled Trials as TopicApoptosisMastectomy, SegmentalColorectal NeoplasmsProspective StudiesTumor Markers, BiologicalBleomycinLomustineRadiotherapy, Computer-AssistedDeoxycytidineActuarial AnalysisAntineoplastic Agents, HormonalProportional Hazards ModelsStomach Neoplasms